ELISABETH LINDNER NEW PRESIDENT AND CEO OF DIAMYD MEDICAL
Press Release, Stockholm, Sweden, December 12, 2007 – Diamyd Medical AB (www.omxgroup.com, ticker: DIAM B; www.otcqx.com, ticker DMYDY)Diamyd Medical announced today that the Board of Directors has appointed Elisabeth Lindner as President and CEO for the Company.Elisabeth Lindner, MSc, MBA, is one of Sweden’s most experienced experts within the biopharmaceutical industry with more than 25 years experience in senior management from positions at Octapharma AB and Pharmacia Corporation, among others.Lindner is also a member of the Board of Directors of NOMX-listed BioInvent International